Reflective Case-Based Oncology Collective™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

Reflective Case-Based Oncology Collective™: Strategic Algorithms for Challenging Cases in Relapsed/Refractory Multiple Myeloma

Philippe Armand, MD, PhD; Sarah C. Rutherford, MD; Tycel J. Phillips, MD

Medical Crossfire®: Unpacking the Latest in Diagnostics and Decision Drivers for Follicular Lymphoma

Nicolas Palaskas, MD, FACC; Daniel Addison, MD; Eric H. Yang, MD, FACC, FASE; Lili Zhang, MD, FACC

Provider and Caregiver Connection Live: Aligning Oncology and Cardiology Care to Identify and Manage ICI-Related Myocarditis

Karen M. Winkfield, MD, PhD; Otis Brawley, MD; Ana Maria Lopez, MD, MPH, MACP, FRCP; Jamil Rivers

Addressing Racial and Ethnic Disparities in Breast Cancer Care: Improving Outcomes Across the Spectrum of Diagnosis, Trial Access, and Patient Care

Reflective Case-Based Oncology Collective™: Translating Recent Evidence on CAR T Cell Therapy to the Real-World Management of Lymphoid Malignancies

Bradley J. Monk, MD, FACS, FACOG; Robert L. Coleman, MD, FACOG, FACS; Domenica Lorusso, MD, PhD; Ursula A. Matulonis, MD

Medical Crossfire®: How Are We Integrating Immune Checkpoint Inhibitors and Targeted Therapies to Personalize Therapy in Endometrial Cancer?

Hope S. Rugo, MD, FASCO; Kevin Kalinsky, MD, MS; Terry P. Mamounas, MD, MPH, FACS; Sara M. Tolaney, MD, MPH

Individualizing Therapy for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer: An Expert Tumor Board Discussion

Aditya Bardia, MD, MPH; Joyce O’Shaughnessy, MD; Mothaffar F. Rimawi, MD

Medical Crossfire®: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer

Maria Dimou, MD, PhD; Matthew S. Davids, MD, MMSc; Karthik Ramasamy, MBBS, FRCP, FRCPath, PhD; Joshua Richter, MD

Medical Crossfire®: How the Experts Differentiate Secondary Immunodeficiencies to Improve Patient Outcomes Across Hematologic Cancer Care

Cancer Summaries and Commentaries: Report from Atlanta on Advancements in the Treatment of ITP

Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

Clinical Consultations™: Evolving Paradigms for the Management of Chronic Kidney Disease and Cardiovascular Comorbidities

Terry P. Mamounas, MD, MPH, FACS; Joyce O’Shaughnessy, MD; David M. Euhus, MD, FACS

Navigating Adjuvant Decision-Making for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer: An Expert Tumor Board Discussion

Omid Hamid, MD; Jeffrey S. Weber, MD, PhD; Rodabe N. Amaria, MD; Ragini Kudchadkar, MD; Sapna Patel, MD

Community Practice Connections™: 18th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Oncology On-Call®: The Experts’ Take on How Sea Changes in GvHD Prophylaxis and Management Can Be Practically Implemented in Your Clinic

Oncology On-Call®: Advancing Care in SCLC with Novel Therapies

Emerging Therapies for Relapsed/Refractory Multiple Myeloma

Virtual Case Studies in Pustular Psoriasis: Refining Our Approaches to the Assessment of Our Patients

Burst Expert Illustrations & Commentaries™: A Clear Focus on Novel Formulations for the Management of Dry Eye Disease

Andre H. Goy, MD; Noopur Raje, MD; Bijal Shah, MD, MS

Community Practice Connections™: CAR T Preconference Workshop

Debu Tripathy, MD; Aditya Bardia, MD, MPH; Claudine Isaacs, MD; Tiffany A. Traina, MD

Community Practice Connections ™: Aligning the Data With Strategy to Improve Breast Cancer Outcomes with PARP, HER2/3, and TROP2 Targeted Regimens

Jorge E. Cortes, MD; Christopher R. Flowers, MD, MS, FASCO; Lori A. Leslie, MD; Sagar Lonial, MD, FACP

Community Practice Connections™: 26th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma 

Nikolai A. Podoltsev, MD, PhD; John Mascarenhas, MD

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

Amy E. DeZern, MD, MHS; Catherine Broome, MD;  Michele P. Lambert, MD, MTR

Community Practice Connections™: Hematology Workshop: Navigating Nonmalignant Diseases in Everyday Practice 

Vallerie V. Mclaughlin, MD; Richard N. Channick, MD

Expert Illustrations & Commentaries™: Finding the Best Path Forward in PAH Management – A Focus on NO-cGMP Signaling

Hossein Borghaei, DO, MS; Lyudmila Bazhenova, MD; Ferdinandos Skoulidis, MD, PhD

Expanding Innovation in NSCLC Through Biomarker Testing and Efforts to Target KRAS G12C

Manesh R. Patel, MD; Marc P. Bonaca, MD, MPH, FAHA, FACC; Jorge Antonio Gutierrez, MD; Amy W. Pollak, MD, MSc, FAHA

Expert Illustrations & Commentaries Live!™: Antithrombotic Approaches to Reduce the Risk of Secondary Events in CAD and PAD

Esen K. Akpek, MD; John D. Sheppard, MD, MMSc, FACS

Advances in™ Sjögren Syndrome-Related Dry Eye Disease: A Focus on Pathophysiology and Clinical Trials

Jenny McDade Despotovic, DO; Laura Dogan, RN, BSN, CPN; Caroline Piatek, MD; Jennifer Russell, A-G NP

Medical Crossfire®: What Role Does the Onco-Nurse Play in the Care and Management of Patients With ITP?

Jared Weiss, MD; Michael Pulley, MD, PhD; Beth Sandy, MSN, CRNP

Virtual Tumor Board®: Multidisciplinary Approaches to Treating Cancer-related LEMS

R. Sharon Chinthrajah, MD; Carla M. Davis, MD; and Edwin H. Kim, MD, MS

The Future of Food Allergy: Novel Treatment Options on the Horizon

Kelley R. Branch, MD, MSc, FACC, FSCCT,Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC

Expert Illustrations & Commentaries™: Protecting Patients with CAD and PAD from Secondary Events with Effective Antithrombotic Strategies

Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting

Angela Fleischman, MD, PhD; Jill Brennan-Cook, DNP, RN-BC, CNE; Natasha Johnson, MSN, APRN, AOCNP; Sandra Kurtin, PhD, ANP-C, AOCN


Cases and Conversations™ With the Oncology Nursing Team: Making Sense of How We Treat MPNs Today and How Novel Strategies Will Shape Patient Care Tomorrow

Joyce O’Shaughnessy, MD; Heather L. McArthur, MD, MPH; Hatem Soliman, MD

Community Practice Connections™: Integrating New Treatment Options into the Management of Triple Negative Breast Cancer

Anjay Rastogi, MD, PhD; Dawn Jacob Laney, MS, CGC, CCRC

Advances In Recognizing and Treating Cardiac and Renal Manifestations in Patients With Fabry Disease

Expert Insights: Current and Future Perspectives for the Management of Neuroendocrine Neoplasms

Genovefa Papanicolaou, MD; Guenther Koehne, MD, PhD; Roy F. Chemaly, MD, MPH, FIDSA, FACP; Sanjeet Dadwal, MD, FACP, FIDSA

Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

Darin T. Okuda, MD, FAAN, FANA; Le H. Hua, MD, FAAN

Advances In™ Personalizing MS Management Plans: Strategies for Optimizing Long-Term Patient Outcomes in MS and Individualizing Treatment within the S1P Receptor Modulator Class

Marc R. Bloomenstein OD, FAAO; Justin Schweitzer, OD, FAAO; Walter Whitley, OD, MBA, FAAO

Community Practice Connections™: Exploring Treatments on the Horizon in MGD-Associated Dry Eye Disease

Joyce O’Shaughnessy, MD; Sunil S. Badve, MD, FRCPath; Judy C. Boughey, MD; Yuan Yuan, MD, PhD

Community Practice Connections™: Testing and Utilization of Ki-67 and Other Prognostic Markers for Clinical Decision-Making in HR-Positive, HER2-Negative Breast Cancer

Charu Aggarwal, MD, MPH; Alexander Drilon, MD; Lynette M. Sholl, MD

Medical Crossfire®: Implications of Tumor Testing Results Across Advanced NSCLC Treatment

Expert Illustrations & Commentaries™: Visualizing New Treatment Pathways for Anemia in Chronic Kidney Disease

Optimizing Care in Inflammatory Bowel Disease (IBD): The Role of Emerging Therapies in Improving Patient Outcomes

Medical Crossfire®: Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care 

Medical Crossfire®: Multidisciplinary Discussions on the Application of Novel EGFR exon 20 Targeted Regimens for NSCLC Management

Hot Seat™: Expert Considerations to Maximize the Clinical Benefits of Targeted Therapies in Patients with Relapsed/Refractory DLBCL

Cases and Conversations: Individualizing Diabetes Care in the Management of Chronic Kidney Disease: Developing the Optimal Treatment Plan With Your Patient

Daniel P. Petrylak, MD; Gert Attard, MD; Celestia (Tia) S. Higano, MD, FACP; Tian Zhang, MD, MHS

Cases and Conversations™: How The Experts Make Evidence-Based Treatment Decisions in Castration-Resistant Prostate Cancer

Diana Jalal, MD; Eugene E. Wright, Jr., MD

Community Practice Connections™: Anemia of Chronic Kidney Disease – Understanding the Disease to Improve Patient Outcomes

Kevin Kalinsky, MD, MS; Heather L. McArthur, MD; MPH, Debu Tripathy, MD; Joyce O'Shaughnessy, MD

Community Practice Connections™: Selecting and Sequencing Therapies Across the Disease Continuum of HER2+ Breast Cancer

Jorge Plutzky, MD; Alison Bailey, MD, FAACVPR, FACC; Nihar R. Desai, MD, MPH; Mary P. McGowan, MD

Community Practice Connections™: Determining When and How to Integrate PCSK9 Inhibition Into Practice

Aditya Bardia, MD, MPH, Adriana D. Corben, MD, Hope S. Rugo, MD, FASCO, Joseph A. Sparano, MD, FACP

Next Generation Sequencing Workshop™: Breast Cancer Edition

September 30, 2022: 8:00 AM – 5:00 PM ET

Expert Perspectives on the Evolving Treatment Paradigm in Heart Failure Management

Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials 

ASCO Direct Highlights™ New York, NY

Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

Cases and Conversations™: Determining When and How to Integrate PCSK9 Inhibition into Practice

How Guidelines and Recent Clinical Trial Data Inform the Modern-Day Treatment of Advanced Prostate Cancer

Medical Crossfire®: Addressing the Top 10 Clinical Challenges in Melanoma

Placing New MPN Therapies into Context Through Illustrated Case Discussions

ASCO Direct Highlights™ - Charlotte

ASCO Direct Highlights™ - Dallas

ASCO Direct Highlights™ Nashville 2022

Understanding Emerging Options in MGD-Associated Dry Eye Disease: Preparing for an Updated Armamentarium

Medical Crossfire®: Leveraging EGFR Mutation Profiles to Personalize Therapeutic Decisions in Resected and Metastatic NSCLC Settings

Medical Crossfire®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

ASCO Direct Highlights™ - Dallas Copy

Victor M. Rivera, MD, FAAN; Robert K. Shin, MD; Mitzi Joi Williams, MD

Community Practice Connections™: Bridging the Gap in Multiple Sclerosis—A Focus on Clinical and Health Care Disparities in Racial-Ethnic Patient Populations

Expert Illustrations & Commentaries™: Visualizing New Therapies in Uveitic Macular Edema – Understanding Impact With an Updated Armamentarium

Michael E. Wechsler, MD, MMSc; Wanda Phipatanakul, MD, MS

Alleviating Asthma Burden—Identifying and Managing Poorly Controlled Disease in Pediatric Patients

Julie R. Brahmer, MD, MSc, FASCO; Rogerio C. Lilenbaum, MD; Mark A. Socinski, MD; Everett E. Vokes, MD

Community Practice Connection™ 19th Annual Winter Lung Cancer Conference®

Immunotherapy Biomarkers and New Targets in Head and Neck Cancer

Advances in™: How Are Evolutions in DLBCL Reshaping Sequencing Considerations?

Joyce O’Shaughnessy MD; Heather L McArthur MD,  MPH; Hatem Soliman MD


Integrating New Treatment Options into the Management of Triple Negative Breast Cancer: An Expert Tumor Board Discussion

Anthony Mato, MD, MSCE; Lindsey Roeker, MD; Chaitra Ujjani, MD

Conversations and Commentaries™: Translating Evolving Data for the Use of BTK Inhibitors in CLL Into Clinical Practice

Arshad M. Khanani MD, MA; Peter K. Kaiser, MD; Sophie J. Bakri, MD

Medical Crossfire®: The Role of Inflammation in the Treatment of Diabetic Macular Edema – Expert Insights and Case Considerations

Patrick I. Borgen, MD; Joshua A. Feinberg, MD; Gary Schwartz, MD

REEL Time:  Improving Recovery Times and Quality of Life With Postoperative Opioid-Sparing Strategies for Patients With Breast Cancer

Courtney DiNardo, MD, MSCE; Keith W. Pratz, MD

Oncology Consultations®: Utilizing Molecular Testing Technologies to Inform Treatment Decision-Making in Acute Myeloid Leukemia

Burst CME™: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment 

William D. Chey, MD, FACG, AGAF, RFF; Bruce E. Sands, MD, MS

3rd Annual Virtual Medical Crossfire® in IBS and IBD

Kevin Kalinsky, MD, MS; Heather L. McArthur, MD, MPH; Debu Tripathy, MD; Joyce O'Shaughnessy, MD

Medical Crossfire®: Selecting and Sequencing Therapies Across the Disease Continuum of HER2+ Breast Cancer

Gary R. Lichtenstein, MD; Bruce E. Sands, MD, MS

Embracing Biosimilars in IBD: How Can We Leverage Them in Our Practice?

Inder Paul Singh, MD, MPH; Elizabeth Yeu, MD

Expert Illustrations & Commentaries™: Visualizing Optimal Astigmatism Management in Cataract Surgery

John D. Sheppard, MD, MMSc, FACS; Noam A. Cohen, MD, PhD; Michael Greenwood, MD; Rishi P. Singh, MD, FASRS; Inder Paul Singh, MD, MPH; Ivan J. Suñer, MD, MBA

(COPE Credit) Clinical Interchange™: Looking Out for Dry Eye Disease in Special Populations—DED Considerations in Glaucoma, Cataracts, Refractive Surgery, and Retinal Diseases

Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It? 

(CME Credit) Clinical Interchange™: Looking Out for Dry Eye Disease in Special Populations—DED Considerations in Glaucoma, Cataracts, Refractive Surgery, and Retinal Diseases

Cancer Summaries and Commentaries™: Updates from Atlanta on the Treatment of MPNs

Benjamin Levy, MD; Melissa L. Johnson, MD; Joshua K. Sabari, MD; Helena Yu, MD

2021 Year in Review: Reflecting on Recent Evidence with an Eye to the Future of Lung Cancer Management

Jason Westin, MD, MS, FACP; Philippe Armand, MD, PhD; Lori A. Leslie, MD; Sonali M. Smith, MD; Pallawi Torka, MD

Bridging Clinical Gaps in B-Cell Lymphomas: Linking Novel Mechanisms to Advance New Treatment Strategies

8th Annual School of Gastrointestinal Oncology® (SOGO®)

Single-Agent PARP Inhibitors and Combination Therapies for Pancreatic Cancer

New York GU™: 16th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Hope S. Rugo, MD, FASCO; Sara M. Tolaney, MD, MPH

Continuing Education